What are you searching for?

Meet the Author

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

Articles by Francesca Gan

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

05.09.2022 | Article

Top 50 Pharma Tracker

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

18.08.2022 | Article

HCPs share frustrations on access and funding issues plaguing the NHS

The NHS has not escaped access and funding issues, and given that it is completely govern...

By Francesca Gan

04.08.2022 | Article

Top 50 Pharma Tracker: HCPs continue to discuss Moderna’s COVID-19 vaccine but…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

02.07.2022 | Article

Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

29.06.2022 | Article

HCPs raise 5 concerns related to long covid

Common issues experienced by sufferers of long covid include, amongst others, fatigue...

By Francesca Gan

06.06.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Pfizer vaccine documents and share opinions…

Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing...

By Francesca Gan and Chawanzi Chintu

05.05.2022 | Article

Top 50 Pharma Tracker: HCPs celebrate the success of Lilly’s tirzepatide for…

Notably this month, HCPs celebrated the efficacy of Lilly’s tirzepatide for obesity patients

By Francesca Gan and Chawanzi Chintu

14.04.2022 | Article

HCPs show concern for racial inequity issues in sickle cell treatment

This is a big issue as SCD is one of the most prevalent genetic diseases, and thus raises...

By Francesca Gan

13.04.2022 | Article

Top 50 Pharma Tracker: HCPs compare immune responses of T cell, B…

Conversations still largely revolved around vaccine efficacy, with HCPs sharing various...

By Francesca Gan and Chawanzi Chintu

11.03.2022 | Article

Top 50 Pharma Tracker: HCPs discuss Healthcare inequity and vaccination of under…

HCPs largely discussed healthcare inequity, comparing the revenue of pharmaceutical...

By Francesca Gan and Chawanzi Chintu

22.02.2022 | Article

What do HCPs think about a fourth COVID vaccine

What do HCPs think about a fourth COVID vaccine

By Francesca Gan

08.02.2022 | Article

Top 50 Pharma Tracker: HCPs get political when discussing Regeneron’s COVID-19 treatment

HCPs get political when discussing Regeneron’s COVID-19 treatment

By Francesca Gan and Chawanzi Chintu

11.01.2022 | Article

Top 50 Pharma Tracker: Omicron variant dominates HCP conversation in December 2021

Discover what healthcare professionals (HCPs) are saying about the Omicron variant

By Francesca Gan and Chawanzi Chintu

22.12.2021 | Article

All HCPs want for Christmas is…

Discover what HCPs wanted for Christmas in 2021

By Paul Cranston and Francesca Gan

01.12.2021 | Article

Top 50 Pharma Tracker: HCPs discuss trial data of Pfizer’s COVID-19 booster…

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Francesca Gan and Chawanzi Chintu

Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations

01.10.2021 | Article

Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations

Discover which new drug approvals and launches HCPs are talking about

By Francesca Gan and Chawanzi Chintu